News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Virbac Corporation (VBAC) Exercises Its Options for a Commercial Licence Agreement to Use Vivalis' EBx(R) Platform



4/1/2008 9:28:46 AM

NANTES, FRANCE--(Marketwire - April 01, 2008) - Highlighted Links VIRBAC EXERCISES ITS OPTION FOR A COMMERCIAL LICENCE AGREEMENT TO USE VIVALIS' EBx® PLATFORM FOR THE PRODUCTION OF SEVERAL VACCINES.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES